Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ratjadones inhibit nuclear export by blocking CRM1/exportin 1.

Mario Köster1, Søren Lykke-Andersen, Yasser A Elnakady

  • 1Department of Gene Regulation and Differentiation, GBF-German Research Centre for Biotechnology, Mascheroder Weg 1, D-38124 Braunschweig, Germany.

Experimental Cell Research
|May 17, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.

Virology journal·2026
Same author

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Cell host & microbe·2025
Same author

Macrophages co-loaded with drug-associated and superparamagnetic nanoparticles for triggered drug release by alternating magnetic fields.

Drug delivery and translational research·2025
Same author

Ultrasound-triggered drug release in vivo from antibubble-loaded macrophages.

Journal of controlled release : official journal of the Controlled Release Society·2024
Same author

A generic cell-based biosensor converts bacterial infection signals into chemoattractants for immune cells.

Biofabrication·2024
Same author

Stable Expression by Lentiviral Transduction of Cells.

Methods in molecular biology (Clifton, N.J.)·2024

New ratjadones B, C, and D from Sorangium cellulosum inhibit eukaryotic proliferation. These compounds block nuclear export by inhibiting the CRM1-RanGTP complex formation, similar to leptomycin B.

Area of Science:

  • Natural Products Chemistry
  • Cell Biology
  • Molecular Pharmacology

Background:

  • Myxobacteria produce diverse bioactive secondary metabolites.
  • Ratjadone A was previously isolated, exhibiting cytotoxic properties.
  • Understanding novel natural products' mechanisms is crucial for drug discovery.

Purpose of the Study:

  • To isolate and characterize new ratjadone analogs (B, C, D) from Sorangium cellulosum.
  • To investigate the biological activity of these ratjadones on mammalian cell lines.
  • To elucidate the molecular mechanism underlying ratjadone-induced cell effects.

Main Methods:

  • Isolation and structural elucidation of ratjadones B, C, and D.
  • Cell-based assays to determine cytotoxicity (IC50 values) and nuclear morphology.

Related Experiment Videos

  • In vitro assays to analyze the inhibition of nuclear export complex formation.
  • Demonstration of ratjadone C binding to CRM1.

    • Main Results:

    • Ratjadones B, C, and D were identified, exhibiting potent activity with IC50 values in the picomolar range.
    • Treatment with ratjadones led to a significant increase in nuclear size.
    • These compounds were shown to inhibit the nuclear export of leucine-rich nuclear export signal (LR-NES) proteins.
    • Ratjadones inhibit the formation of the CRM1-RanGTP-cargo protein complex and bind to CRM1.

    Conclusions:

    • Ratjadones represent a new class of natural compounds with potent anti-proliferative activity.
    • Their mechanism involves the inhibition of CRM1-mediated nuclear export, similar to leptomycin B.
    • These findings highlight the potential of ratjadones as novel therapeutic agents targeting eukaryotic proliferation.